Journal of Immunology Research

Recent Advances in the Immunopathogenesis and Immunotherapy of Autoimmune Diseases


Publishing date
01 Jan 2020
Status
Closed
Submission deadline
06 Sep 2019

Lead Editor

1Cellular Therapy Laboratory, Winnipeg, Canada

2Institute of Clinical Medicine, Beijing, China

3Immunology Program, New York, USA

This issue is now closed for submissions.
More articles will be published in the near future.

Recent Advances in the Immunopathogenesis and Immunotherapy of Autoimmune Diseases

This issue is now closed for submissions.
More articles will be published in the near future.

Description

Autoimmune diseases are conditions arising from the abnormal immune responses against normal self-tissues, organs, or cells. The incidence and prevalence of autoimmune diseases have markedly increased over the second half of the 20th century and has become a major health problem. In autoimmune diseases, cell destruction is elicited by activated T cells, B cells, and other immune cells that are inappropriately directed to and respond to self-antigens, leading to loss of tissue function. Autoimmune diseases are usually chronic and can be life-threating. Recent advances have greatly increased our understanding of the pathogenesis of autoimmune diseases, and it is widely accepted that environment, genes, and immunity contribute to the development of these diseases. These advances may therefore aid in the development of effective immunotherapeutic strategies.

This special issue invites authors to submit original research and review articles that seek to explore the immunopathogenesis of autoimmune diseases. Submissions that explore potential treatment/targets or develop novel strategies for the treatment of these diseases are welcomed. Individual case reports and clinical trials in this field are also welcomed.

Potential topics include but are not limited to the following:

  • Identifying novel immunopathogenetic mechanisms of autoimmune diseases
  • Identifying potential targets for the treatment of autoimmune diseases
  • Identifying potential biomarkers correlated with autoimmune disease severity or treatment efficacy
  • Development of novel immunotherapeutic strategies for autoimmune diseases
  • Clinical and preclinical evaluation of novel immunotherapies in the treatment of autoimmune diseases

Articles

  • Special Issue
  • - Volume 2020
  • - Article ID 8459496
  • - Review Article

Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell

Chaopin Yang | Yue Li | ... | Zhiyi Chen
  • Special Issue
  • - Volume 2020
  • - Article ID 1561278
  • - Research Article

Plasma MicroRNA Expression Profiles in Psoriasis

Shiju Xiao | Xin Liu | ... | Guangzhong Zhang
  • Special Issue
  • - Volume 2020
  • - Article ID 9624532
  • - Review Article

Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy

Manal Ali Buabeid | El-Shaimaa A. Arafa | Ghulam Murtaza
  • Special Issue
  • - Volume 2019
  • - Article ID 5727516
  • - Review Article

Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases

Yuehong Chen | Jianhong Sun | ... | Qibing Xie
  • Special Issue
  • - Volume 2019
  • - Article ID 1324804
  • - Research Article

Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation

Maël Lateb | Hajar Ouahmi | ... | Barbara Seitz-Polski
  • Special Issue
  • - Volume 2019
  • - Article ID 5821589
  • - Research Article

Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models

Kunio Sugahara | Yasuhiro Maeda | ... | Hirotoshi Kataoka
  • Special Issue
  • - Volume 2019
  • - Article ID 9827574
  • - Research Article

miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA

Shiwen Yuan | Chun Tang | ... | Xiaoyan Cai
  • Special Issue
  • - Volume 2019
  • - Article ID 7247238
  • - Review Article

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease

Qingdong Guan
  • Special Issue
  • - Volume 2019
  • - Article ID 8380214
  • - Review Article

Advances in the Research on Anticardiolipin Antibody

Dan Wang | Wenxin Lv | ... | Jiexin Zhang
  • Special Issue
  • - Volume 2019
  • - Article ID 3638562
  • - Review Article

Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus

Fangyuan Yang | Yi He | ... | Erwei Sun
Journal of Immunology Research
 Journal metrics
Acceptance rate40%
Submission to final decision65 days
Acceptance to publication30 days
CiteScore3.330
Impact Factor3.404
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.